Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Pharmacotherapeutic options for kidney disease in HIV positive patients
Anam Tariq
, Hannah Kim
, Hashim Abbas
, Gregory M. Lucas
, Mohamed G. Atta
Department of Pediatrics
Research output
:
Contribution to journal
›
Review article
›
peer-review
7
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacotherapeutic options for kidney disease in HIV positive patients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
HIV Patients
100%
Kidney Disease
100%
Pharmaceutics
100%
HIV-associated
100%
Combined Antiretroviral Therapy (cART)
100%
HIV-positive
50%
Literature Search
25%
Multidisciplinary Team
25%
Comorbidity
25%
United States
25%
Healthcare Professionals
25%
Creatinine
25%
Risk Factors
25%
Expert Opinion
25%
Risk Stratification
25%
MEDLINE
25%
Current Recommendations
25%
Co-infection
25%
Drug Interactions
25%
Kidney Transplant
25%
Drug Toxicity
25%
Chronic Kidney Disease
25%
Area Cover
25%
Dose Adjustment
25%
Antiretroviral Therapy Initiation
25%
Scopus
25%
Kidney Disease Progression
25%
Kidney Disease: Improving Global Outcomes (KDIGO)
25%
End-stage Kidney Disease
25%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Nephropathy
100%
Antiretroviral Therapy
66%
End Stage Renal Disease
33%
Chronic Kidney Disease
33%
Clinician
16%
Kidney Graft
16%
Risk Stratification
16%
Creatinine
16%
Mixed Infection
16%
HIV Therapy
16%
Comorbidity
16%
Side Effect
16%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Kidney Disease
100%
Chronic Kidney Failure
33%
End Stage Renal Disease
33%
Creatinine
16%
HIV Therapy
16%
Mixed Infection
16%
Comorbidity
16%
Side Effect
16%